Pharmaceutical 2003
August 3rd, 2008Pharmaceutical 2003
Sumitomo Pharmaceuticals 2003 | News Release | Dainippon Sumitomo ...
Healthy bodies, healthy lives. Official corporate site of Dainippon Sumitomo Pharma. ... New Oita Plant Facilities for Bulk Pharmaceuticals Production and Meropen Formulation ... (more...)
Pharmaceutical cGMPs A Risk-Based Approach (TOC)
FDA Press Release (issued September 3, 2003) Pharmaceutical cGMPs for the 21st Century ? A Risk-Based Approach: Second Progress Report and Implementation Plan (issued ... (more...)
PAR Pharmaceutical
December 3, 2003 Peter W. Williams Elected to Board of Directors of Pharmaceutical Resources, Inc. December 1, 2003 Par Pharmaceutical to Begin Shipment of Metformin ... (more...)
Tags:
PAR
Pharmaceutical
Medication - Wikipedia, the free encyclopedia
esomeprazole: Nexium: AstraZeneca: 3.3 (2003) Fexofenadine: Telfast/Allegra: Aventis: 1.87 (2004) ... Accessed 17 August 2008. ^ Pharmaceutical Market Trends, 2006-2010, from Urch Publishing ^ ... (more...)
UK Pharmaceuticals 2003 (Snapshots International) doi:10.1337/uk301753
The Complete Market Research Toolbox. Snapdata Market Research-- Market Snapshots -- Market Size -- Market Values -- Market Volumes -- Market Shares -- Market Segmentation ... (more...)
SciClone Pharmaceuticals: 2003 Press Releases
2003 Press Releases December 2003 December-1-2003 Sciclone Pharmaceuticals to Present at Harris Nesbitt Gerard Healthcare Conference October 2003 (more...)
Poland Pharmaceuticals 2003 (Snapshots International) doi:10.1337 ...
The Complete Market Research Toolbox. Snapdata Market Research-- Market Snapshots -- Market Size -- Market Values -- Market Volumes -- Market Shares -- Market Segmentation ... (more...)
ELCA Corporate Social Responsiblity: Issue Paper - International ...
FW 8 DW 8 XHTML ... RECOMMENDED by the Advisory Committee on Corporate Social Responsibility, September 6, 2003. (more...)
Watson Pharmaceuticals | Welcome to Watson!
Welcome to Watson's Web site, your portal to understanding our business and the vision, legacy, and quality that are shaping our impressive growth. (more...)
Lupin Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc. entered the U.S. generic pharmaceutical market in 2003 with the ANDA approval for cefuroxime axetil. (more...)